1. Yanqiang Wang, Sandya Liyanarachchi, Katherine E. Miller, Taina T. Nieminen, Daniel F. Comiskey Jr., Wei Li, Pamela Brock, David E. Symer, Keiko Akagi, Katherine E. DeLap, Huiling He, Daniel C. Koboldt, and Albert de la Chapelle. Identification of rare variants predisposing to thyroid cancer. Thyroid. Jul;29(7): 946-955, 2019.
2. Yanqiang Wang, Huiling He, Sandya Liyanarachchi, Luke K. Genutis, Wei Li, Lianbo Yu, John Phay, Rulong Shen, Pamela Brock, and Albert de la Chapelle. The role of SMAD3 in the genetic predisposition to papillary thyroid carcinoma. Genetics in Medicine, Sep;20(9):927-935, 2018.
3. Yanqiang Wang, Huiling He, Wei Li, John Phay, Rulong Shen, Lianbo Yu, Baris Hancioglu, and Albert de la Chapelle. MYH9 binds to lncRNA gene PTCSC2 and regulates FOXE1 in the 9q22 thyroid cancer risk locus. Proceedings of The National Academy of Sciences of The United States of America. Vol. 114, 474-479, 2017.
4. Yanqiang Wang, Wei Li, John Phay, Rulong Shen, Natalia S. Pellegata, Motoyasu Saji, Matthew D. Ringel, Albert de la Chapelle, and Huiling He. Primary Cell Culture Systems for Human Thyroid Studies. Thyroid. Vol. 26, 1131-1140, 2016.
5.CDCA7 facilitates tumor progression by directly regulating CCNA2 expression in esophageal squamous cell carcinoma. Hongyi Li, Yongjia Weng, Shaojie Wang, Fang Wang, Yanqiang Wang, Pengzhou Kong, Ling Zhang, Caixia Cheng, Heyang Cui, Enwei Xu, Shuqing Wei, Dinghe Guo, Fei Chen, Yanghui Bi, Yongsheng Meng, Xiaolong Cheng and Yongping Cui. Frontiers in Oncology. 2021 Oct 19;11:734655.
6.The role of DBR1 as a candidate prognosis biomarker in esophageal squamous cell carcinoma. Xu, Xiaoqin; Yang, Xin; Liu, Xue; Bi, Yanghui; Kong, Pengzhou; Wang, Yanqiang; Cheng, Xiaolong; Xi, Yanfeng. Technology in Cancer Research & Treatment. 2022 Jan-Dec; 21.
7.Integrative Genomic Analyses of 1,145 Patient Samples Reveal New Biomarkers in Esophageal Squamous Cell Carcinoma. Binbin Zou, Dinghe Guo, Pengzhou Kong, Yanqiang Wang, Xiaolong Cheng and Yongping Cui. Front Mol Biosci. 2022 Jan 21;8:792779.
8.FAT1 downregulation enhances stemness and cisplatin resistance in esophageal squamous cell carcinoma. Yuanfang Zhai, Chengyuan Shan, Haoyu Zhang, Pengzhou Kong, Ling Zhang, Yanqiang Wang, Xiaoling Hu, Xiaolong Cheng. Mol Cell Biochem. 2022, Dec;477(12):2689-2702.
9.Elevated FAM84B promotes cell proliferation via interacting with NPM1 in esophageal squamous cell carcinoma. Fang Wang, Caixia Cheng, Xinhui Wang, Fei Chen, Hongyi Li, Yan Zhou, Yanqiang Wang, Xiaoling Hu, Pengzhou Kong, Ling Zhang, Xiaolong Cheng, Yongping Cui. Cell Death Discov. 2022 Apr 8;8(1):182.
10.CDCA7 promotes TGF-β1-induced epithelial-mesenchymal transition via transcriptionally regulating SMAD4/SMAD7 in esophageal squamous cell carcinoma. Hongyi Li, Shaojie Wang, Dinghe Guo, Yongjia Weng, Pengzhou Kong, Caixia Chen, Yanqiang Wang, Ling Zhang, Xiaolong Cheng, Yongping Cui. Cancer Science. 2023,Jan;114(1):91-104.
